MediciNova Announces Presentation of Positive Findings on MN-001 (tipelukast) in Acute Liver Injury Model at The Liver Meeting Digital Experience™ 2020

    NEXT STORY
    INNATE PHARMA RECEIVES PRIME DESIGNATION FROM THE EUROPEAN MEDICINES AGENCY FOR LACUTAMAB IN SÉZARY SYNDROME
    PREV STORY
    AS COMMUNITY COVID-19 CASES RISE, RENOWN PREPARES
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Global In Silico/Computer-Aided Drug Discovery Services Market: Focus on Large Molecules (2020-2030)

    author_avatar
    NASDAQ Market News

    RedHill Biopharma Announces Enrollment of 300th Patient in Confirmatory Phase III Study with TALICIA® for H. pylori Infection

    Approximately 70% of the planned total of 444 patients have been enrolled in the ...

    author_avatar
    NASDAQ Market News

    THE CORTALE GROUP Promotes Health and Wellness

    author_avatar
    NASDAQ Market News